ResearchMultiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia
ResearchOncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination
ResearchAssociations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors
ResearchRisk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
ResearchMolecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
ResearchInterplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
ResearchThe prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
ResearchClinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
ResearchVenetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
ResearchImplications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
ResearchAllogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study